Targeting von Willebrand factor and platelet glycoprotein Ib receptor (Q33392975)

26 July 2017

Targeting von Willebrand factor and platelet glycoprotein Ib receptor (English)

1 reference

26 July 2017

Jolanta M Siller-Matula

object named as

Jolanta M Siller-Matula

series ordinal

2

0 references

Bernd Jilma

series ordinal

3

object named as

Bernd Jilma

1 reference

26 July 2017

Christa Firbas

1

1 reference

26 July 2017

1 December 2010

1 reference

Expert Review of Cardiovascular Therapy

26 July 2017

1 reference

26 July 2017

8

1 reference

26 July 2017

12

1 reference

26 July 2017

1689-1701

1 reference

von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.

26 July 2017

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Biochemistry and genetics of von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Mouse models of von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Platelet adhesion receptors and their ligands in mouse models of thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Synthesis of von Willebrand factor by cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Normal endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Transplantation of normal bone marrow into a pig with severe von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Platelet von Willebrand factor in inherited and acquired bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Synthesis of Factor VIII Antigen by Cultured Guinea Pig Megakaryocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

The effects of epinephrine infusion in patients with von Willebrand's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Von Willebrand disease - phenotype versus genotype: deficiency versus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Classification of inherited von Willebrand disease and implications in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-he

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Resistance development to fluoroquinolones in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Processing of von Willebrand factor by ADAMTS-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Platelet adhesion to multimerin 1 in vitro: influences of platelet membrane receptors, von Willebrand factor and shear

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Co-existence of heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura in a postoperative cardiac surgery patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Kidney involvement in thrombotic thrombocytopenic purpura and malignant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Thrombotic microangiopathy: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

The role of ADAMTS13 in the new pathogenesis of TTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Survival and relapse in patients with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Systemic antithrombotic effects of ADAMTS13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Structure and function of snake venom toxins interacting with human von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Platelet function predicts myocardial damage in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact-R).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

The effect of ex vivo anticoagulants on whole blood platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Pharmacokinetics and pharmacodynamics of AJW200, a humanized monoclonal antibody to von Willebrand factor, in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Discovery and development of therapeutic aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Engineering and characterization of a chimeric anti-platelet glycoprotein Ibalpha monoclonal antibody and preparation of its Fab fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Deficiency of von Willebrand factor protects mice from ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

ADAMTS13: a new link between thrombosis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

Inhibition of Platelet Glycoprotein Ib, Glycoprotein IIb/IIIa, or Both by Monoclonal Antibodies Prevents Arterial Thrombosis in Baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.10.154

21 January 2018

Identifiers

DOI

10.1586/ERC.10.154

1 reference

26 July 2017

1 reference

PubMed ID

21108551